Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26001579 | 0.95 | CA12 (0.36) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL26001511 | 0.95 | CA12 (0.34) | CA12CA1CA2CA9KDM4E | |
| SCHEMBL26001506 | 0.94 | SIGMAR1 (0.33) | SIGMAR1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL24772380 | 0.93 | CA12 (0.34) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL24772227 | 0.93 | CA12 (0.34) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL23457497 | 0.93 | CA12 (0.33) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL26001520 | 0.93 | CHRNA1 (0.32) | CA12CA1CA2CA9KDM4E | |
| SCHEMBL26001576 | 0.93 | CA12 (0.35) | CA12CA1CA2CA9KDM4E | |
| SCHEMBL23458420 | 0.92 | CA12 (0.31) | CA12CA1CA2CA9 | |
| SCHEMBL26001528 | 0.92 | CA12 (0.31) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4238956-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPLIANCE | Idemitsu Kosan Co., Ltd. (JP) | 2023-09-06 | — | — | EP | disclosed |
| US-20230262999-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230262999-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20220399501-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2022-12-15 | — | — | US | disclosed |
| WO-2021107736-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220399501-A1 | ORGANIC LIGHT-EMITTING ELEMENT | CYP1A1, AHR, CYP1B1 | SIGMAR1 1172/4885CA12 3571/4885CA1 4001/4885 |
| US-20230262999-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, LEF1, L1CAM | SIGMAR1 3098/4885CA12 1567/4885CA1 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.